CTD-ILD

Clinical trials for CTD-ILD explained in plain language.

Never miss a new study

Get alerted when new CTD-ILD trials appear

Sign up with your email to follow new studies for CTD-ILD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug aims to protect lungs in autoimmune patients

Disease control Not yet recruiting

This Phase 3 trial tests whether the drug telitacicept can slow the decline in lung function in people with connective tissue disease-related interstitial lung disease (CTD-ILD). About 260 adults with conditions like rheumatoid arthritis or lupus and confirmed lung scarring will …

Matched conditions: CTD-ILD

Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

CTD-ILD

Get alerted when new CTD-ILD trials appear

New drug aims to protect lungs in autoimmune patients